Catharina Wenzel

1.8k total citations
48 papers, 1.4k citations indexed

About

Catharina Wenzel is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Catharina Wenzel has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 15 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Catharina Wenzel's work include Cancer Treatment and Pharmacology (15 papers), HER2/EGFR in Cancer Research (14 papers) and Breast Cancer Treatment Studies (12 papers). Catharina Wenzel is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), HER2/EGFR in Cancer Research (14 papers) and Breast Cancer Treatment Studies (12 papers). Catharina Wenzel collaborates with scholars based in Austria, United States and Switzerland. Catharina Wenzel's co-authors include Guenther G. Steger, Rupert Bartsch, Christoph Zielinski, Margaretha Rudas, Michael Gnant, Ursula Pluschnig, Robert M. Mader, R. Jakesz, Gottfried J. Locker and Gabriela Altorjai and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Catharina Wenzel

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catharina Wenzel Austria 22 979 403 376 223 221 48 1.4k
Lorenzo Gianni Italy 21 1.2k 1.2× 600 1.5× 526 1.4× 163 0.7× 405 1.8× 91 2.0k
M. Luisa Paccagnella United States 13 857 0.9× 210 0.5× 275 0.7× 283 1.3× 409 1.9× 22 1.7k
Stew Kroll United States 16 515 0.5× 371 0.9× 400 1.1× 335 1.5× 310 1.4× 31 1.6k
N. Pavlidis Greece 14 894 0.9× 736 1.8× 442 1.2× 422 1.9× 191 0.9× 38 1.5k
S.M. O'Reilly United Kingdom 14 641 0.7× 354 0.9× 294 0.8× 137 0.6× 225 1.0× 26 1.2k
Paul Richards United States 20 869 0.9× 342 0.8× 266 0.7× 438 2.0× 281 1.3× 42 1.4k
А. Н. Махсон Russia 15 1.2k 1.3× 397 1.0× 563 1.5× 112 0.5× 310 1.4× 23 1.7k
A. Antón Spain 18 1.3k 1.3× 492 1.2× 695 1.8× 104 0.5× 178 0.8× 103 1.7k
P Hurteloup France 15 975 1.0× 410 1.0× 429 1.1× 217 1.0× 297 1.3× 32 2.0k
R. Largillier France 14 940 1.0× 527 1.3× 334 0.9× 231 1.0× 162 0.7× 47 1.5k

Countries citing papers authored by Catharina Wenzel

Since Specialization
Citations

This map shows the geographic impact of Catharina Wenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catharina Wenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catharina Wenzel more than expected).

Fields of papers citing papers by Catharina Wenzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catharina Wenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catharina Wenzel. The network helps show where Catharina Wenzel may publish in the future.

Co-authorship network of co-authors of Catharina Wenzel

This figure shows the co-authorship network connecting the top 25 collaborators of Catharina Wenzel. A scholar is included among the top collaborators of Catharina Wenzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catharina Wenzel. Catharina Wenzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janata, Karin, Catharina Wenzel, Rudolf Járai, et al.. (2011). The role of ST-segment elevation in lead aVR in the risk assessment of patients with acute pulmonary embolism. Clinical Research in Cardiology. 101(5). 329–337. 15 indexed citations
2.
Bartsch, Rupert, Margaretha Rudas, Alexander de Vries, et al.. (2008). Factors influencing the time to development of brain metastases in breast cancer. The Breast. 17(5). 512–516. 9 indexed citations
3.
Bartsch, Rupert, Catharina Wenzel, Simon Peter Gampenrieder, et al.. (2008). Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 62(5). 903–910. 28 indexed citations
4.
Bartsch, Rupert, Brigitte Mlineritsch, Michael Gnant, et al.. (2008). The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer. Breast Cancer Research and Treatment. 115(2). 373–380. 10 indexed citations
5.
Bartsch, Rupert, Catharina Wenzel, Christoph Zielinski, & Guenther G. Steger. (2007). HER-2-Positive Breast Cancer. BioDrugs. 21(2). 69–77. 31 indexed citations
6.
Bartsch, Rupert, Andrea Rottenfusser, Catharina Wenzel, et al.. (2007). Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer. Journal of Neuro-Oncology. 85(3). 311–317. 113 indexed citations
7.
Wenzel, Catharina, Rupert Bartsch, Ursula Pluschnig, et al.. (2006). Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF. Breast Cancer Research and Treatment. 104(1). 109–114. 34 indexed citations
8.
Bartsch, Rupert, Catharina Wenzel, Ursula Pluschnig, et al.. (2006). Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study. BMC Cancer. 6(1). 63–63. 41 indexed citations
9.
Wenzel, Catharina, Gottfried J. Locker, Rupert Bartsch, et al.. (2005). Preoperative second-line chemotherapy induces objective responses in primary breast cancer. Wiener klinische Wochenschrift. 117(1-2). 48–52. 4 indexed citations
10.
Wenzel, Catharina, Rupert Bartsch, Gottfried J. Locker, et al.. (2005). Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer. Anti-Cancer Drugs. 16(4). 441–445. 12 indexed citations
11.
Bartsch, Rupert, Catharina Wenzel, Ursula Pluschnig, et al.. (2005). Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial. Cancer Chemotherapy and Pharmacology. 57(5). 554–558. 15 indexed citations
12.
Bartsch, Rupert, Catharina Wenzel, Marco Hassler, et al.. (2005). Retrospective analysis of re-irradiation in malignant glioma: a single-center experience. Wiener klinische Wochenschrift. 117(23-24). 821–826. 8 indexed citations
13.
Fazeny-Dörner, Barbara, Mario Veitl, Catharina Wenzel, et al.. (2003). Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme. Anti-Cancer Drugs. 14(6). 437–442. 30 indexed citations
14.
Wenzel, Catharina, Gottfried J. Locker, Ursula Pluschnig, et al.. (2002). Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer. Cancer Chemotherapy and Pharmacology. 50(2). 155–159. 15 indexed citations
15.
Fazeny-Dörner, Barbara, Mario Veitl, Catharina Wenzel, et al.. (2002). Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine). Cancer Chemotherapy and Pharmacology. 49(4). 294–298. 19 indexed citations
16.
Wenzel, Catharina, Gottfried J. Locker, Manuela Schmidinger, et al.. (2002). Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor. Anti-Cancer Drugs. 13(1). 67–74. 21 indexed citations
17.
Wenzel, Catharina, Brigitte Stoiser, Gottfried J. Locker, et al.. (2002). Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions. Critical Care Medicine. 30(4). 763–770. 49 indexed citations
18.
Wenzel, Catharina, Karin Dieckmann, Wolfgang Fiebiger, et al.. (2001). CD5 Expression in a Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT)-Type as a Marker for Early Dissemination and Aggressive Clinical Behaviour. Leukemia & lymphoma. 42(4). 823–829. 39 indexed citations
19.
Locker, Gottfried J., Catharina Wenzel, Manuela Schmidinger, et al.. (2001). Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients. Anti-Cancer Drugs. 12(3). 209–212. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenzo Gianni Breakdown of academic impact, for papers by M. Luisa Paccagnella Breakdown of academic impact, for papers by Stew Kroll Breakdown of academic impact, for papers by N. Pavlidis Breakdown of academic impact, for papers by S.M. O'Reilly Breakdown of academic impact, for papers by Paul Richards Breakdown of academic impact, for papers by А. Н. Махсон Breakdown of academic impact, for papers by A. Antón Breakdown of academic impact, for papers by P Hurteloup Breakdown of academic impact, for papers by R. Largillier
Rankless by CCL
2026